Experimental chemotherapy of Schistosomiasis III: laboratory and clinical trials with trichlorphone, an organophosphorus compound

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Organophosphorus Compound Induced 'Intermediate Syndrome'

Potential use of Dental Pulp Stem Cell in Laboratory Studies and Clinical Trials

Stem cell-based therapy has great potential in treating health conditions including cardiovascular, autoimmune, type I diabetes, neurodegenerative and bone and cartilage diseases also in spinal cord injuries, malformations and cancer. In addition to their potential use to treat systemic diseases, stem cell-based therapy also provides a powerful tool to treat oral and dental diseases such as cra...

Phase III clinical trials: tPA in the experimental setting

Dr. Gladstone is a Stroke Fellow in the Division of Neurology, Department of Medicine, Sunnybrook and Women’s College Health Sciences Centre, and is a trainee in the Royal College of Physicians and Surgeons of Canada’s Clinician Investigator Program at the University of Toronto, Toronto, Ont. Dr. Black is Head, Division of Neurology, and Codirector, Stroke Research Unit, Sunnybrook and Women’s ...

Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials

1 Duke University, Center for AIDS Research Central QA Unit, Durham, North Carolina, United States of America, 2 International AIDS Vaccine Initiative, Rockville, Maryland, United States of America, 3 Henry M. Jackson Foundation for the Advancement of Military Medicine–Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health an...